196 related articles for article (PubMed ID: 16595992)
1. Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemia.
Higuchi T; Matsukawa Y; Okada K; Oikawa O; Yamazaki T; Ohnishi Y; Fujita T; Fukuda N; Soma M; Matsumoto K
Intern Med; 2006; 45(5):271-3. PubMed ID: 16595992
[TBL] [Abstract][Full Text] [Related]
2. [Erythropoietin resistant anemia and neutropenia due to copper deficiency during long-term enteral nutrition on maintained hemodialysis].
Shimizu S; Uriu K; Takagi I; Mine S; Tounai S; Kuriyama M; Oda E; Tanaka A; Tanaka Y; Tsukada J
Nihon Naika Gakkai Zasshi; 2007 Jan; 96(1):138-40. PubMed ID: 17305065
[No Abstract] [Full Text] [Related]
3. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.
Carlini R; Obialo CI; Rothstein M
Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228
[TBL] [Abstract][Full Text] [Related]
4. Effect of hemodialysis and recombinant human erythropoietin on determinants of blood viscosity.
Shand BI; Buttimore AL; Lynn KL; Bailey RR; Robson RA
Ren Fail; 1994; 16(3):407-13. PubMed ID: 8059023
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.
Shrivastava D; Rao TK; Sinert R; Khurana E; Lundin AP; Friedman EA
Am J Kidney Dis; 1995 Jun; 25(6):904-9. PubMed ID: 7771487
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin-free dialysate improves response to erythropoietin in hemodialysis patients.
Matsuhashi N; Yoshioka T
Nephron; 2002; 92(3):601-4. PubMed ID: 12372943
[TBL] [Abstract][Full Text] [Related]
7. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
Massimetti C; Pontillo D; Feriozzi S; Costantini S; Capezzuto A; Ancarani E
Blood Purif; 1998; 16(6):317-24. PubMed ID: 10343078
[TBL] [Abstract][Full Text] [Related]
8. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO).
Campos A; Garin EH
Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282
[TBL] [Abstract][Full Text] [Related]
9. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients.
Robertson HT; Haley NR; Guthrie M; Cardenas D; Eschbach JW; Adamson JW
Am J Kidney Dis; 1990 Apr; 15(4):325-32. PubMed ID: 2321645
[TBL] [Abstract][Full Text] [Related]
10. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin treatment of anemia in renal transplant patients.
Lezaic V; Djukanovic L; Pavlovic-Kentera V
Ren Fail; 1995 Nov; 17(6):705-14. PubMed ID: 8771243
[TBL] [Abstract][Full Text] [Related]
12. Mathematical approach for estimating iron needs in hemodialysis patients on erythropoietin therapy.
Tarng DC; Huang TP; Chen TW
Am J Nephrol; 1997; 17(2):158-64. PubMed ID: 9096447
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin treatment in children with renal failure.
Van Damme-Lombaerts R; Herman J
Pediatr Nephrol; 1999 Feb; 13(2):148-52. PubMed ID: 10229005
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of hematological disorders caused by copper deficiency during long-term enteral nutrition.
Nagano T; Toyoda T; Tanabe H; Nagato T; Tsuchida T; Kitamura A; Kasai G
Intern Med; 2005 Jun; 44(6):554-9. PubMed ID: 16020879
[TBL] [Abstract][Full Text] [Related]
15. Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia?
Eschbach JW; Varma A; Stivelman JC
Nephrol Dial Transplant; 2002; 17 Suppl 5():2-7. PubMed ID: 12091599
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial.
Beiraghdar F; Panahi Y; Einollahi B; Nemati E; Ghadiani MH; Sahebkar A; Maghsoudi N; Marzony ET
Clin Lab; 2012; 58(7-8):737-45. PubMed ID: 22997974
[TBL] [Abstract][Full Text] [Related]
17. Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease.
Muirhead N; Churchill DN; Goldstein M; Nadler SP; Posen G; Wong C; Slaughter D; Laplante P
Am J Nephrol; 1992; 12(5):303-10. PubMed ID: 1488998
[TBL] [Abstract][Full Text] [Related]
18. [Anemia and neutropenia in elderly patients caused by copper deficiency for long-term enteral nutrition].
Banno S; Niita M; Kikuchi M; Wakita A; Takada K; Mitomo Y; Niimi T; Yamamoto T
Rinsho Ketsueki; 1994 Nov; 35(11):1276-81. PubMed ID: 7823395
[TBL] [Abstract][Full Text] [Related]
19. Occult infection and resistance of anaemia to rHuEpo therapy in renal failure.
Muirhead N; Hodsman AB
Nephrol Dial Transplant; 1990; 5(3):232-4. PubMed ID: 2113653
[No Abstract] [Full Text] [Related]
20. Anemia of chronic renal failure: treatment with erythropoietin.
Navarro M; Alonso A; Avilla JM; Espinosa L
Child Nephrol Urol; 1991; 11(3):146-51. PubMed ID: 1777893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
